News & Articles
Selected Filters:
Quantitative proteomics advances disease modeling and drug development
Learn how Inotiv’s proteomics services are helping researchers gain deeper insights into drug target systems, to better select disease models, and quantify pathology data
BioMed X and Novo Nordisk launch new collaboration in oral peptide drug delivery
The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists
SelectScience membership survey 2025
As part of our aim to improve our service to scientists and laboratory professionals, we invite you to complete the SelectScience 2025 survey
Could organ-on-a-chip models help replace animal drug testing?
As the FDA and NIH plan to phase out animal-based drug testing, organ-chip models are filling this critical gap
Rethinking lab informatics for the next generation of therapeutics
Biopharma needs informatics platforms that are unified, flexible, and intelligent – ready not just for today’s science, but for what is coming next
How multiomics and AI advance drug discovery
Dr. Michael Kiebish of BPGbio shares insight into its AI-powered NAi Interrogative Biology Platform and discusses the growing importance of multiomic data
ChemPartner’s bispecific ADC platform accelerates oncology drug discovery
The comprehensive preclinical screening platform was validated using HER2 x TROP2 bsADC as a proof of concept
Thermo Fisher Scientific launches new Heratherm Environmental Chamber for regulated environments
To help simulate exact environmental conditions for shipping, storage, or research environments, offering repeatable and consistent performance
Cytiva launches new ÄKTA readyflux system for smaller scale manufacturing
Designed to support drug developers in bringing their therapeutics to market faster, more efficiently, and with greater reliability
How FcRn mouse models from JAX reveal antibody half-life and stability
Advancing clinical pharmacokinetic prediction beyond non-human primate models
Digital transformation maximizes lab automation impact
With smarter tools, AI-powered insights, and a focus on user experience, lab automation is becoming more accessible, flexible, and impactful than ever
How Tecan’s Veya is bringing effortless automation to multiomics
With intuitive workflows, quick setup, and expert support, Veya is making automation accessible and cost-effective for first-time users
Oligo pools to power innovation in protein engineering
Learn how advances in massively parallel oligo synthesis are driving protein engineering, synthetic gene assembly, and functional genomics research
A new era of DNA synthesis: Improving speed, scalability and sustainability
This guest editorial outlines how the collaboration between Camena Bioscience and SPT Labtech is driving innovation in the field of DNA synthesis
GLP-1 unpacked – Evaluating benefits, limitations and future clinical directions
Guest editorial features key takeaways from Balancing the Future Podcast, by METTLER TOLEDO
Centauri Therapeutics appoints Dr. Debra Barker as Chief Medical Officer
Experienced clinical immunologist and global life science executive to support progression of lead candidate through the clinic
HORIBA opens new Analytical Solution Plaza to support UK science and research
New UK-based technical innovation facility opens in Nuneaton on MIRA Tech Park
Nasal COVID vaccine shows promise in phase 1 clinical trial
A nasal vaccine could prove both more effective medically and more tolerable for young children and adults who may fear needles
GenNext Technologies and Thermo Fisher Scientific unite to simplify structural biology
New workflow streamlines protein structural analysis and supports the growing role of AI in drug discovery
Integrating LC-MS and ligand binding assays to meet bioanalytical demands
How two CROs are uniting ligand-binding assays and LC-MS expertise to tackle the complexity of modern biologics
Enhanced Genomics and The ALBORADA Drug Discovery Institute partner to accelerate Alzheimer's drug discovery
Breakthrough demonstrates the potential of 3D multi-omics to revolutionize drug discovery timelines and success rates across various disease area
Anti-AAV antibody testing emerges as key to gene therapy
Advance gene therapy precision by reliably testing pre-existing AAV immunogenicity
Velp Scientifica unveils its new brand identity
A renewed image for a company in constant evolution, driven by curiosity
























